The effect of catechol-O-methyltransferase polymorphisms on pain is modified by depressive symptoms

European Journal of Pain (United Kingdom)

Volumn 16, Issue 6, 2012, Pages 878-889

  Schwahn, C ^a   Grabe, H J ^a   Meyer Zu Schwabedissen, H ^a   Teumer, A ^a   Schmidt, C O ^a   Brinkman, C ^a   Kocher, T ^a   Nauck, M ^a   Volzke H ^a   Biffar, R ^a   Bernhardt, O ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CATECHOL METHYLTRANSFERASE; THIOREDOXIN REDUCTASE 2;

ADULT; AGED; ARTHRALGIA; ARTICLE; CAUCASIAN; CLINICAL EXAMINATION; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYALGIA; PAIN; PALPATION; POPULATION RESEARCH; PRIORITY JOURNAL; RURAL AREA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CATECHOL O-METHYLTRANSFERASE; CHRONIC PAIN; DEPRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 84867726163     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/j.1532-2149.2011.00067.x     Document Type: Article

References (56)

1. Apkarian AV, Baliki MN, Geha PY. Towards a theory of chronic pain. Prog Neurobiol 2009;87:81-97.
2. Arias B, Serretti A, Lorenzi C, Gasto C, Catalan R, Fananas L. Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin. J Affect Disord 2006;90:251-6.
3. Bair MJ, Robinson RL, Katon W, Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med 2003;163:2433-45.
4. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-5.
5. Baune BT, Hohoff C, Berger K, Neumann A, Mortensen S, Roehrs T, et al. Association of the COMT val158met variant with antidepressant treatment response in major depression. Neuropsychopharmacology 2008;33:924-32.
6. Bernhardt O, Gesch D, Schwahn C, Mack F, Meyer G, John U, et al. Risk factors for headache, including TMD signs and symptoms, and their impact on quality of life. Results of the Study of Health in Pomerania (SHIP). Quintessence Int 2005;36:55-64.
7. Bernhardt O, Schiffman EL, Look JO. Reliability and validity of a new fingertip-shaped pressure algometer for assessing pressure pain thresholds in the temporomandibular joint and masticatory muscles. J Orofac Pain 2007;21:29-38.
8. Blackburn-Munro G, Blackburn-Munro RE. Chronic pain, chronic stress and depression: coincidence or consequence? J Neuroendocrinol 2001;13:1009-23.
9. Buscher HC, van Goor H, Sweep CG, Lenders JW, Wilder-Smith OH. Increased sympathetic activity in chronic pancreatitis patients is associated with hyperalgesia. J Pain Palliat Care Pharmacother 2010;24:362-6.
10. De Kanter RJ, Truin GJ, Burgersdijk RC, Van 'T Hof MA, Battistuzzi PG, Kalsbeek H, et al. Prevalence in the Dutch adult population and a meta-analysis of signs and symptoms of temporomandibular disorder. J Dent Res 1993;72:1509-18.
11. Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, Max MB, et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006;125:216-24.
12. Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005;14:135-43.
13. Drangsholt MT. Psychological characteristics such as depression, independent from a known genetic risk factor, increase the risk of developing temporomandibular disorder pain. J Evid Based Dent Pract 2008;8:240-1.
14. Elliott AM, Smith BH, Penny KI, Smith WC, Chambers WA. The epidemiology of chronic pain in the community. Lancet 1999;354:1248-52.
15. Fijal B, Perlis RH, Heinloth AN, Houston JP. The association of single nucleotide polymorphisms in the catechol-Omethyltransferase gene and pain scores in female patients with major depressive disorder. J Pain 2010;11:910-5.
16. Fishbain DA, Cutler R, Rosomoff HL, Rosomoff RS. Chronic pain-associated depression: antecedent or consequence of chronic pain? A review. Clin J Pain 1997;13:116-37.
17. Fletcher RH, Fletcher SW. Clinical epidemiology: the essentials, 4th edn. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins; 2005.
18. Grabe HJ, Baumeister SE, John U, Freyberger HJ, Völzke H. Association of mental distress with health care utilization and costs: a 5-year observation in a general population. Soc Psychiatry Psychiatr Epidemiol 2009a;44:835-44.
19. Grabe HJ, Spitzer C, Schwahn C, Marcinek A, Frahnow A, Barnow S, et al. Serotonin transporter gene (SLC6A4) promoter polymorphisms and the susceptibility to posttraumatic stress disorder in the general population. Am J Psychiatry 2009b;166:926-33.
20. Grabe HJ, Meyer C, Hapke U, Rumpf HJ, Freyberger HJ, Dilling H, et al. Somatoform pain disorder in the general population. Psychother Psychosom 2003;72:88-94.
21. Hensel E, Gesch D, Biffar R, Bernhardt O, Kocher T, Splieth C, et al. Study of Health in Pomerania (SHIP): a health survey in an East German region. Objectives and design of the oral health section. Quintessence Int 2003;34:370-8.
22. Hessel A, Beutel M, Geyer M, Schumacher J, Brahler E. Prevalence of somatoform pain complaints in the German population. Psychosoc Med 2005;2:Doc03.
23. Hocking LJ, Smith BH, Jones GT, Reid DM, Strachan DP, Macfarlane GJ. Genetic variation in the beta2-adrenergic receptor but not catecholamine-O- methyltransferase predisposes to chronic pain: results from the 1958 British Birth Cohort Study. Pain 2010;149:143-51.
24. Janal MN, Raphael KG, Nayak S, Klausner J. Prevalence of myofascial temporomandibular disorder in US community women. J Oral Rehabil 2008;35:801-9.
25. Ji Y, Olson J, Zhang J, Hildebrandt M, Wang L, Ingle J, et al. Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms. Cancer Res 2008;68:5997-6005.
26. John MT, Miglioretti DL, LeResche L, Von Korff M, Critchlow CW. Widespread pain as a risk factor for dysfunctional temporomandibular disorder pain. Pain 2003;102:257-63.
27. John U, Greiner B, Hensel E, Ludemann J, Piek M, Sauer S, et al. Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed 2001;46:186-94.
28. Khasar SG, Dina OA, Green PG, Levine JD. Sound stressinduced long-term enhancement of mechanical hyperalgesia in rats is maintained by sympathoadrenal catecholamines. J Pain 2009;10:1073-7.
29. Kim DH, Schwartz CE. The genetics of pain: implications for evaluation and treatment of spinal disease. Spine J 2010; 10:827-40.
30. Kim H, Clark D, Dionne RA. Genetic contributions to clinical pain and analgesia: avoiding pitfalls in genetic research. J Pain 2009;10:663-93.
31. Kim H, Dionne RA. Comment on Diatchenko et al. Catechol-O- methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006;125:216-24.
32. Pain 2007;129:365-6. author reply 366-70.
33. Knol MJ, van der Tweel I, Grobbee DE, Numans ME, Geerlings MI. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol 2007;36:1111-8.
34. LeResche L, Mancl L, Sherman JJ, Gandara B, Dworkin SF. Changes in temporomandibular pain and other symptoms across the menstrual cycle. Pain 2003;106:253-61.
35. LeResche L, Mancl LA, Drangsholt MT, Huang G, Von Korff M. Predictors of onset of facial pain and temporomandibular disorders in early adolescence. Pain 2007;129:269-78.
36. Lieb R, Meinlschmidt G, Araya R. Epidemiology of the association between somatoform disorders and anxiety and depressive disorders: an update. Psychosom Med 2007; 69:860-3.
37. Look JO, Schiffman EL, Truelove EL, Ahmad M. Reliability and validity of Axis I of the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) with proposed revisions. J Oral Rehabil 2010;37:744-59.
38. Lunn DJ, Whittaker JC, Best N. A Bayesian toolkit for genetic association studies. Genet Epidemiol 2006;30:231-47.
39. McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007; 87:873-904.
40. Mukherjee N, Kidd KK, Pakstis AJ, Speed WC, Li H, Tarnok Z, et al. The complex global pattern of genetic variation and linkage disequilibrium at catechol-O-methyltransferase. Mol Psychiatry 2010;15:216-25.
41. Nackley AG, Shabalina SA, Lambert JE, Conrad MS, Gibson DG, Spiridonov AN, et al. Low enzymatic activity haplotypes of the human catechol-O- methyltransferase gene: enrichment for marker SNPs. PLoS ONE 2009;4:e5237.
42. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, et al. Human catechol-Omethyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006;314:1930-3.
43. Nicholl BI, Holliday KL, Macfarlane GJ, Thomson W, Davies KA, O'Neill TW, et al. No evidence for a role of the catechol-O-methyltransferase pain sensitivity haplotypes in chronic widespread pain. Ann Rheum Dis 2010; 69:2009-12.
44. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004;74:765-9.
45. Okeson JP. Comprehensive physical examination. In: Okeson JP, editor. Orofacial pain: Guidelines for assessment, diagnosis, and management. Chicago, Illinois: Quintessence Publishing; 1996. pp. 23-7.
46. Rothman KJ. Epidemiology: an introduction. New York: Oxford University Press; 2002.
47. Rothman KJ, Greenland S, Lash TL. Case-control studies. In: Rothman KJ, Greenland S, Lash TL, editors. Modern epidemiology. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins; 2008a. pp. 111-27.
48. Rothman KJ, Greenland S, Lash TL. Validity in epidemiologic studies. In: Rothman KJ, Greenland S, Lash TL, editors. Modern epidemiology. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins; 2008b. pp. 128-47.
49. Rothman KJ, Greenland S, Poole C, Lash TL. Causation and causal inference. In: Rothman KJ, Greenland S, Lash TL, editors. Modern epidemiology. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins; 2008c. pp. 5-31.
50. Schmidt CO, Baumeister SE. Simple patterns behind complex spatial pain reporting? Assessing a classification of multisite pain reporting in the general population. Pain 2007;133:174-82.
51. Schwahn C, Grabe HJ. Gene-environment interactions and depression. JAMA 2009;302:1860-1.
52. Scrivani SJ, Keith DA, Kaban LB. Temporomandibular disorders. N Engl J Med 2008;359:2693-705.
53. Shibata K, Diatchenko L, Zaykin DV. Haplotype associations with quantitative traits in the presence of complex multilocus and heterogeneous effects. Genet Epidemiol 2009; 33:63-78.
54. Slade GD, Diatchenko L, Bhalang K, Sigurdsson A, Fillingim RB, Belfer I, et al. Influence of psychological factors on risk of temporomandibular disorders. J Dent Res 2007; 86:1120-5.
55. Wittchen HU, Höfler M, Gander F, Pfister H, Storz S, Bedirhan Ü, et al. Screening for mental disorders: performance of the Composite International Diagnostic - Screener (CID-S). Int J Methods Psychiatr Res 1999;8:59-70.
56. Zhang J, Ji Y, Moon I, Pelleymounter LL, Ezequel Salavaggione O, Wu Y, et al. Catechol O-methyltransferase pharmacogenomics: human liver genotype-phenotype correlation and proximal promoter studies. Pharmacogenet Genomics 2009;19:577-87.